Influenza

Flu vaccine maker taking action to return to market as reliable supplier

Published in Drug Week, November 26th, 2004

Chiron Corporation (CHIR) provided the following statement in response to the recent announcement by U.S. health officials:

[helv]Chiron profoundly regrets that it is unable to meet the public health needs for the current influenza season. The company is committed to resolving the concerns raised by regulatory authorities in the United Kingdom and the United States.

Chiron intends to take appropriate action at its Liverpool facility so that the company may fulfill its commitment to protecting health with a reliable supply of Fluvirin influenza virus vaccine.

The company expects to work closely with both the U.K. regulatory body,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-11-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry